Who Qualifies for Ozempic or Wegovy? Eligibility Explained

Why Eligibility Matters

If you've looked into GLP-1 medications like Ozempic or Wegovy, you've probably run into the question of whether you actually qualify for them. It's a genuinely important question, and not just a bureaucratic hurdle. These are powerful prescription medications with real effects and real risks, and the eligibility criteria exist to match them to the people most likely to benefit and least likely to be harmed.

Understanding the criteria helps in a few ways. It tells you whether a prescription is a realistic option before you invest time and hope in it. It clarifies why your doctor might say yes or no. And it helps you understand the difference between the various semaglutide products, which are frequently confused with one another. This article walks through who qualifies for Ozempic, who qualifies for Wegovy, how the two differ, and — importantly — what your options are if you don't meet the criteria.

One thing to establish at the outset: the final decision always rests with a qualified prescriber who can assess your complete medical picture. The criteria below describe the general FDA-approved framework, but they are not a substitute for a clinical evaluation. Think of this as a map, not a diagnosis.

Ozempic Versus Wegovy: Same Drug, Different Purpose

Before getting into who qualifies, it's essential to clear up a point of confusion that trips up almost everyone: Ozempic and Wegovy contain the same active medication, semaglutide, but they are approved for different purposes and are not interchangeable.

Ozempic is FDA-approved to treat type 2 diabetes in adults. Its job, officially, is to help manage blood sugar, and it's also approved to reduce the risk of major cardiovascular events (like heart attack and stroke) in adults who have both type 2 diabetes and established heart disease.

Wegovy is a higher-dose version of semaglutide approved specifically for weight management — for chronic weight management in people with obesity, or in people who are overweight and also have a weight-related health condition.

Why does this distinction matter for eligibility? Because the criteria are tied to the approved use. If your goal is weight loss and you don't have diabetes, Wegovy is the relevant product, and its weight-based criteria apply. If you have type 2 diabetes, Ozempic is the diabetes-focused product. Sometimes people ask for "Ozempic for weight loss" specifically — that's a use outside its official indication (prescribing a drug off-label is legal and common, but it's a clinical decision, and insurance coverage often follows the official indication). Getting the terminology right helps you have a clearer conversation with your doctor.

Who Qualifies for Wegovy (Weight Management)

For most people whose primary goal is weight loss, Wegovy's criteria are the relevant ones, and they're built around body mass index (BMI) plus health conditions.

The general FDA-approved criteria for adults are: a BMI of 30 or higher (which falls into the "obesity" category), or a BMI of 27 or higher (the "overweight" category) accompanied by at least one weight-related health condition.

What counts as a weight-related condition? Common examples include high blood pressure (hypertension), high cholesterol or abnormal lipids (dyslipidemia), and type 2 diabetes, among others. The logic is that at a somewhat lower BMI, the presence of one of these conditions raises the stakes enough that the benefits of treatment are more likely to outweigh the risks.

There's also an adolescent indication: Wegovy is approved for certain adolescents aged 12 and older with obesity, which reflects growing recognition of obesity as a treatable medical condition earlier in life. And in a notable expansion, semaglutide has also received approval related to reducing cardiovascular risk in certain adults with obesity or overweight and established cardiovascular disease — broadening who might be considered beyond weight alone.

BMI itself deserves a quick honest caveat: it's a crude tool. It doesn't distinguish muscle from fat or account for body composition and distribution, so it's an imperfect gatekeeper. But it's the standard the criteria are built on, and a prescriber uses it as a starting point alongside the rest of your health picture, not as the only factor.

Who Qualifies for Ozempic (Type 2 Diabetes)

Ozempic's eligibility is more straightforward because it's tied to a diagnosis rather than a BMI threshold.

The core criterion is a diagnosis of type 2 diabetes in an adult. Ozempic is prescribed to help manage blood sugar, typically alongside diet and exercise, and often when other diabetes treatments haven't achieved adequate control or as part of a broader treatment plan.

The additional cardiovascular indication applies to a narrower group: adults who have both type 2 diabetes and established heart disease, where Ozempic can reduce the risk of major cardiovascular events. This is a meaningful benefit for a higher-risk population and can factor into a prescriber's decision.

What Ozempic is not officially approved for is weight loss in people without diabetes. Because it contains semaglutide — the same compound as Wegovy — it does produce weight loss, which is why it became famous for that. But prescribing Ozempic purely for weight loss in a non-diabetic person is off-label. That's a legal and sometimes reasonable clinical choice, but it's the prescriber's call, and it often runs into insurance obstacles because coverage tends to track the official indication. If weight loss is the goal, Wegovy is generally the on-label route.

What Determines the Final Decision

The BMI numbers and diagnoses above are the framework, but a real prescribing decision involves more, and it's worth understanding what else goes into it.

A prescriber will typically consider your full medical history, including conditions that might make a GLP-1 medication risky or inadvisable. There are specific contraindications and warnings for semaglutide — for example, it carries a boxed warning related to a type of thyroid tumor seen in rodent studies, and it's not appropriate for people with a personal or family history of medullary thyroid carcinoma or a condition called multiple endocrine neoplasia syndrome type 2. A history of pancreatitis, certain gastrointestinal conditions, pregnancy, and other factors also weigh into the decision.

Your prescriber will also weigh what you've already tried, your other medications (for interactions), your ability to tolerate likely side effects (nausea and other GI effects are common early on), and your overall goals. Eligibility, in other words, is a conversation and an assessment — not just a BMI calculation. Two people with identical BMIs might get different recommendations based on everything else in their charts.

This is also why telehealth services that prescribe these medications still require a medical evaluation. Even when the process is quick and online, a legitimate provider is checking these boxes. If a service offers to prescribe with no real evaluation at all, that's a red flag worth heeding.

What to Do If You Don't Qualify

Plenty of people who want a GLP-1 medication don't meet the criteria — perhaps their BMI is below the threshold without a qualifying condition, or a contraindication rules it out, or they can access a prescription but can't afford it. This is a common and frustrating situation, and it deserves an honest answer rather than a sales pitch.

First, talk to your doctor about why you don't qualify and what that means. Sometimes the answer reveals other useful paths: structured lifestyle and behavioral weight-management programs (which have real evidence), other weight-loss medications with different criteria, addressing a specific underlying condition, or, in some cases, referral to an obesity-medicine specialist who can look deeper.

Second — and this is important to say plainly — not qualifying for a GLP-1 drug does not mean a supplement is an equivalent substitute. It's tempting, when a proven medication is out of reach, to reach for something marketed as a "natural alternative." But the honest evidence gap is large. Semaglutide produced about 14.9% average body-weight loss in a major trial; supplements like berberine show far smaller, less certain effects — roughly a kilogram on average in meta-analyses.

That doesn't mean supplements are worthless — berberine may support metabolic health for some people, and if you're curious, the honest berberine weight loss evidence is worth reading with clear eyes. But treating a supplement as a stand-in for a medication you'd have benefited from is a mistake, especially if you have a real medical condition. If cost is the barrier rather than eligibility, that's worth exploring directly too — see our guide on options when you can't afford Ozempic, which covers assistance programs and legitimate avenues. The through-line: bring the "I don't qualify" or "I can't afford it" problem to a professional, because there are often better answers than self-substituting.

Bottom Line

Eligibility for GLP-1 medications comes down to matching the right product to the right person. Wegovy, the weight-management version of semaglutide, is generally for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition like high blood pressure, high cholesterol, or diabetes (plus certain adolescents, and an expanded cardiovascular indication for some). Ozempic, the diabetes version, is for adults with type 2 diabetes, and for cardiovascular risk reduction in diabetics with established heart disease. Both contain semaglutide but are not interchangeable.

The final decision always involves a prescriber weighing your complete medical picture — your BMI or diagnosis, yes, but also contraindications like thyroid cancer history, other medications, tolerance for side effects, and your goals. That's why even fast telehealth options require a genuine evaluation.

If you don't qualify, the productive move is to talk with your doctor about the reasons and the alternatives, which may include lifestyle programs, other medications, or specialist referral. And it's worth being clear-eyed about one thing: not qualifying for a highly effective medication doesn't make a supplement an equal replacement. Supplements can play a modest supporting role for some people, but they aren't a substitute for proven medical treatment — so let a professional help you find the path that actually fits your situation.

Related Articles

• Can't Afford Ozempic? Here Are Your Real Options in 2026
• Berberine vs. Ozempic: The Honest Comparison
• The Complete Guide to Berberine for Weight Loss
• Purisaki Berberine Patches Review 2026